QIAGEN Reports Results for Fourth Quarter and Full-Year 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Qiagen (QGEN) Tops Q4 EPS by 4c, Revenues Beat; Offers FY20 EPS Guidance Above Consensus
February 4, 2020 4:15 PM ESTQiagen (NYSE: QGEN) reported Q4 EPS of $0.48, $0.04 better than the analyst estimate of $0.44. Revenue for the quarter came in at $413.5 million versus the consensus estimate of $408.58 million.
Delivers on Q4 2019 net sales outlook, exceeds on adjusted EPSNet sales of $413.5 million (+3% actual, +4% CER, vs. ~+3% CER outlook)Diluted EPS $0.19; adjusted EPS $0.48 ($0.48 CER, +20% CER vs. ~$0.45-0.46 CER outlook)Adjusted operating income margin rises to 33.5% of sales vs. 29.6% in Q4 2018Achieves FY 2019 net sales outlook, exceeds on adjusted EPSNet sales of $1.53 billion (+2% actual, +4% CER, vs. ~+4% CER outlook)Net loss per... More